Skip to content

Ginkgo Bioworks Holdings, Inc.

DNA· NYSECore metricsCIK 1830214

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -0.39%
Market cap
$658.84M
64.5M shares
Filings
1,043
$27.71M
Q3 2026−25.1% FY25 yoy
-$40.98M
Q3 2026N/M FY25 yoy
-$43.63M
Q3 2026N/M FY25 yoy
-$125.86M
Q3 2026derivedN/M FY25 yoy
-$5.64
FY 2025N/M FY25 yoy
$84.50M
Q3 2026−70.2% FY25 yoy
$658.84M
—
5.0×
1.7×
-26.34%
—

Twelve months to Sep 30, 2026 · derived

Price

$10.22+21.10%+$1.78past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$170.16MFY 2025
$477.71M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$170,155,000reported
FY 20242024-12-31$227,043,000reported
FY 20232023-12-31$251,455,000reported
FY 20222022-12-31$477,706,000reported
FY 20212021-12-31$313,837,000reported
FY 20202020-12-31$76,657,000reported
FY 20192019-12-31$54,184,000reported

Capital returns

Dividends and buybacks · FY2019 to FY2023
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2023—$0.00$0.00—50.03M sh−97.4%—
FY2022—$0.00$0.00—1.89B sh+17.4%—
FY2021—$25.00M$25.00M—1.61B sh+25.1%—
FY2020—$0.00$0.00—1.29B sh——
FY2019—$408.00K$408.00K————

Segments

Revenue by Segments, FY2021 to FY2025FY2021Cell Engineering · FY2021 · $112.99MBiosecurity · FY2021 · $200.85MFY2022Cell Engineering · FY2022 · $143.67MBiosecurity · FY2022 · $334.04MFY2023Cell Engineering · FY2023 · $143.53MBiosecurity · FY2023 · $107.92MFY2024Cell Engineering · FY2024 · $173.97MFY2025Cell Engineering · FY2025 · $132.75M
LineFY2025ShareChange
Cell Engineering$132.75M78%−23.7%
Biosecurity———
Total$170.16M

From the 10-K filed Feb 26, 2026DNA

Biological products, except diagnostic substances

Ginkgo Bioworks Holdings, Inc. is the 24th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Ginkgo Bioworks Holdings, Inc. · CIK 1830214 · Engraved from SEC EDGAR